Fragment-Based Drug Discovery

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
== Paclitaxel in Apoptosis ==
+
== Rasagiline Analogues in Monoamine Oxidase Inhibition ==
-
<StructureSection load='1ysi' size='350' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[1ysi]])' scene=''>
+
<StructureSection load='2c64' size='350' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[2c64]])' scene=''>
-
This represents the inhibition of the anti-apoptotic protein, Bcl-xl, by and anti-cancer drug, paclitaxel.
+
This represents the irreversible and selective inhibition of MAO-B by rasagiline.
</StructureSection>
</StructureSection>

Revision as of 19:15, 17 September 2012

Rasagiline Analogues in Monoamine Oxidase Inhibition

Structure of HMG-CoA reductase (PDB entry 2c64)

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Justin Weekley, Arthur Cox, Jaime Prilusky

Retrieved from "http://52.214.119.220/wiki/index.php/Fragment-Based_Drug_Discovery"
Personal tools